CBP Says India is Country of Origin for Ponstel
CBP said it issued a final determination of the country of origin of Ponstel (mefenamic acid) capsules, deciding that India is the country of origin for purposes of U.S. government procurement. Parties have until Feb. 8 to seek judicial review of the final determination.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
The determination was issued at the request of West-Ward Pharmaceutical Corp. CBP concluded that mefenamic acid from India, blended with excipients and packaged into dosage form in the U.S., was not substantially transformed in the U.S., so India is the country of origin of the finished Ponstel.
Further information: Heather Pinnock, 202-325-0034.